Clinical Trials Directory

Trials / Sponsors / Inhibrx Biosciences, Inc

Inhibrx Biosciences, Inc

Industry · 6 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingINBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 / Phase 32024-05-14
Active Not RecruitingStudy of INBRX-109 in Conventional Chondrosarcoma
Conventional Chondrosarcoma
Phase 22021-09-23
Active Not RecruitingStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanc
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer
Phase 1 / Phase 22019-12-10
CompletedPhase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency, AATD
Phase 12019-07-19
TerminatedStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Canc
Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma
Phase 12019-01-30
RecruitingPhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Ewing Sarcoma
Phase 12018-10-08